Patients' perspectives on being included in medical product decision making


Including patient perspectives in medical product development and decision making is of increasing interest to patients themselves, physicians, authorities, and the pharmaceutical industry. Patient preference studies allows patients to influence decisions and drug development. CRB's Karin Schölin Bywall was interviewed on the subject by the Swedish Rheumatism Association. 

Find out more about Karin Schölin Bywall's research, or follow the link below to read the interview in its entirety. 

Full story (in Swedish)

More news from CRB